The Preliminary Study for Postoperative Radiotherapy Survival Associated with RUNX3 and TLR9 Expression in Lung Cancer

References

• Chen K , Huang J , Gong W , Iribarren P , Dunlop NM , Wang JM . Toll-like receptors in inflmmation, infection and cancer. Int Immunopharmacol . 2007;7:1271–1285. doi:10.1016/j.intimp.2007.05.016 17673142
   PubMed Web of Science ®Google Scholar
• Droemann D , Albrecht D , Gerdes J , et al. Human lung cancer cells express functionally active Toll-like receptor 9. Respir Res . 2005;6:1. doi:10.1186/1465-9921-6-1 15631627
   PubMed Web of Science ®Google Scholar
• Merrell MA , Ilvesaro JM , Lehtonen N , et al. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res . 2006;4:437–447. doi:10.1158/1541-7786.MCR-06-0007 16849519
   PubMed Web of Science ®Google Scholar
• Takala H , Kauppila JH , Soini Y , et al. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression. J Innate Immun . 2011;3:631–638. doi:10.1159/000329115 21876325
   PubMed Web of Science ®Google Scholar
• Ren T , Xu L , Jiao S , et al. TLR9 signaling promotes tumor progression of human lung cancer cell In vivo. Pathol Oncol Res . 2009;15(4):623–630. doi:10.1007/s12253-009-9162-0 19319670
   PubMed Web of Science ®Google Scholar
• Xu L , Wang C , Wen Z , et al. CpG oligodeoxynucleotides enhance the efficacy of adoptive cell transfer using tumor infiltrating lymphocytes by modifying the Th1 polarization and local infiltration of Th17 cells. Clin Dev Immunol . 2010;2010:410893. doi:10.1155/2010/410893 20981279
   PubMedGoogle Scholar
• Kundu SD , Lee C , Billips BK , et al. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate . 2008;68(2):223–229. doi:10.1002/pros.20710 18092352
   PubMed Web of Science ®Google Scholar
• Väisänen MR , Väisänen T , Jukkola-Vuorinen A , et al. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors. Prostate . 2010;70(8):817–824. doi:10.1002/pros.21115 20054821
   PubMed Web of Science ®Google Scholar
• Kauppila JH , Takala H , Selander KS , Lehenkari PP , Saarnio J , Karttunen TJ . Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology . 2011;59(4):643–649. doi:10.1111/j.1365-2559.2011.03991.x 22014045
   PubMed Web of Science ®Google Scholar
• Wang C , Cao S , Yan Y , et al. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients. BMC Cancer . 2010;10:415. doi:10.1186/1471-2407-10-415 20696081
   PubMed Web of Science ®Google Scholar
• Bae SC , Choi JK . Tumor suppressor activity of RUNX3. Oncogene . 2004;23(24):4336–4340. doi:10.1038/sj.onc.1207286 15156190
   PubMed Web of Science ®Google Scholar
• Bangsow C , Rubins N , Glusman G , et al. The RUNX3 gene-sequence, structure and regulated expression. Gene . 2001;279(2):22l–232. doi:10.1016/S0378-1119(01)00760-0
   Web of Science ®Google Scholar
• Milner JJ , Toma C , Yu B , et al. Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumors. Nature . 2017;552(7684):253–257. doi:10.1038/nature24993 29211713
   PubMed Web of Science ®Google Scholar
• Mami-Chouaib F , Blanc C , Corgnac S , et al. Resident memory T cells, critical components in tumor immunology. J ImmunoTher Cancer . 2018;6:87. doi:10.1186/s40425-018-0399-6 30180905
   PubMed Web of Science ®Google Scholar
• Djuretic IM , Levanon D , Negreanu V , Groner Y , Rao A , Ansel KM . Transcription factors T-bet and Runx3 cooperate to activate IFN-γ and silence IL4 in T helper type 1 cells. Nat Immunol . 2006;8(7):145–153.17195845
   PubMed Web of Science ®Google Scholar
• Torres-Roca JF , Eschrich S , Zhao H , et al. Prediction of radiation sensitivity using a gene expression classifier. Cancer Res . 2005;65:7169–7176. doi:10.1158/0008-5472.CAN-05-0656 16103067
   PubMed Web of Science ®Google Scholar
• Esteller M . Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet . 2007;16(1):R50–R59. doi:10.1093/hmg/ddm018 17613547
   PubMed Web of Science ®Google Scholar
• Kim HJ , Kim JH , Chie EK , et al. DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity. Radiat Oncol . 2012;7(1):39. doi:10.1186/1748-717X-7-39 22429326
   PubMed Web of Science ®Google Scholar
• Valdez BC , Li Y , Murray D , Corn P , Champlin RE , Andersson BS . 5-Aza-2′-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis. Leuk Res . 2010;34(3):364–372. doi:10.1016/j.leukres.2009.08.014 19732952
   PubMed Web of Science ®Google Scholar
• Oing C , Verem I , Mansour WY , Bokemeyer C , Dyshlovoy S , Honecker F . 5-Azacitidine exerts prolonged pro-apoptotic effects and overcomes cisplatin-resistance in non-seminomatous germ cell tumor cells. Int J of Mol Sci . 2019;20:21. doi:10.3390/ijms20010021
   Web of Science ®Google Scholar
• Yan L , Xu G , Qiao T , Chen W , Yuan S , Li X . CpG ODN 7909 increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of toll-like receptor 9. Cancer Biother Radiopharm . 2013;28(7):559–564. doi:10.1089/cbr.2012.1450 23705865
   PubMed Web of Science ®Google Scholar
• Takeda K , Kaisho T , Akira S . Toll-like receptors. Annu Rev Immunol . 2003;21:335–376. doi:10.1146/annurev.immunol.21.120601.141126 12524386
   PubMed Web of Science ®Google Scholar
• Hoshino K , Kaisho T , Lwabe T , Takeuchi O , Akira S . Differential involvement of IFN-beta in Toll-like receptor stimulated dendritic cell activation. Int Immunol . 2002;14(10):1225–1231. doi:10.1093/intimm/dxf089 12356687
   PubMed Web of Science ®Google Scholar
• Johnson GB , Brunn GJ , Tang AH , Platt JL . Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol . 2003;24(1):19–24.12495720
   PubMed Web of Science ®Google Scholar
• Peter M , Bode K , Lipford GB , Eberle F , Heeg K , Dalpke AH . Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor 9 mediated activation of innate immunity. Immunology . 2008;123(1):118–128. doi:10.1111/j.1365-2567.2007.02718.x 17961163
   PubMed Web of Science ®Google Scholar
• Serafini P , De Santo C , Marigo I , et al. Derangement of immune responces by myeloid suppressor cells. Cancer Immunol Lmmunother . 2004;53(2):64–72. doi:10.1007/s00262-003-0443-2
   PubMed Web of Science ®Google Scholar
• Yano T , Ito K , Fukamachi H , et al. The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transfoming growth factor β-induced apoptosis. Mol Cell Biol . 2006;26:4474–4488. doi:10.1128/MCB.01926-05 16738314
   PubMed Web of Science ®Google Scholar
• Durst KL , Hiebert SW . Role of RUNX family members in transcriptional repression and gene silencing. Oncogene . 2004;23(24):4220–4224. doi:10.1038/sj.onc.1207122 15156176
   PubMed Web of Science ®Google Scholar
• Ohno S , Sato T , Kohu K , et al. Runx proteins are involved in regulation of CDl22, Ly49 family and IFN-γ expression during NK cell differentiation. Int Immunol . 2008;20(1):7l–79. doi:10.1093/intimm/dxm120
   Web of Science ®Google Scholar
• Taniuchi I , Littman DR . Epigenetic gene silencing by Runx proteins. Oncogene . 2004;23(24):4341–4345. doi:10.1038/sj.onc.1207671 15156191
   PubMed Web of Science ®Google Scholar
• Sato T , Ohno S , Hayashi T , et al. Dual functions of Runx proteins for reactivating CD8 and silencing CD4 at the commitment process into CD8 thymocytes. Immunity . 2005;22(3):317–328. doi:10.1016/j.immuni.2005.01.012 15780989
   PubMed Web of Science ®Google Scholar
• Schulz EG , Mariani L , Radbruch A , Höfer T . Sequential polarization and imprinting of type l T helper lymphocytes by interferon-γ and interleukin-12. Immunity . 2009;30(5):673–683. doi:10.1016/j.immuni.2009.03.013 19409816
   PubMed Web of Science ®Google Scholar
• Wolff EM , Liang G , Cortez CC , et al. RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. Cancer Res . 2008;68(15):6208–6214. doi:10.1158/0008-5472.CAN-07-6616 18676844
   PubMed Web of Science ®Google Scholar